Jefferies Financial Group’s Coherus Oncology CHRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$426K	Sell	252,000 -143,190	-36%	-$254K	0.01%	1273
2025 Q4	$561K	Buy	395,190 +69,565	+21%	+$101K	﹤0.01%	1301
2025 Q3	$534K	Buy	325,625 +8,000	+3%	+$8.9K	﹤0.01%	1062
2025 Q2	$232K	Hold	317,625	–	–	﹤0.01%	1092
2025 Q1	$256K	Buy	317,625 +10,000	+3%	+$11.5K	﹤0.01%	1297
2024 Q4	$425K	Buy	307,625 +25,000	+9%	+$28K	﹤0.01%	1157
2024 Q3	$294K	Buy	282,625 +86,000	+44%	+$118K	﹤0.01%	1121
2024 Q2	$340K	Hold	196,625	–	–	0.01%	1081
2024 Q1	$470K	Buy	196,625 +113,000	+135%	+$278K	0.01%	1077
2023 Q4	$278K	Buy	83,625 +43,000	+106%	+$115K	﹤0.01%	1386
2023 Q3	$152K	Buy	+40,625	New	+$188K	﹤0.01%	1393
2023 Q2	–	Sell	-130,625	Closed	-$893K	–	1726
2023 Q1	$893K	Buy	130,625 +106,000	+430%	+$823K	0.02%	934
2022 Q4	$195K	Buy	+24,625	New	+$189K	﹤0.01%	1303